We use cookies

We use cookies on our website. Some of them are essential while others help us improve this website and your experience.

Essential
 
Health

Scientific publication

Secukinumab, a novel anti-IL-17A antibody, can be quantified in skin after a single dose by dermal open flow microperfusion (dOFM)

Publication from Health

Bruin G., Dragatin C. , Aigner B., Polus F., Calonder C., Froeliger C., Tiffner K., Bodenlenz M., Mader J., Korsatko S., Ratzer R., Pieber T. R., Loesche C., Sinner F.

Journal der Deutschen Dermatologischen Gesellschaft 12:15-15, 2014